ID   CL1-0
AC   CVCL_3871
AS   CVCL_D516
SY   CL 1-0; CL1.0; CL1
DR   BTO; BTO:0002875
DR   ChEMBL-Cells; CHEMBL4482997
DR   ChEMBL-Targets; CHEMBL4483232
DR   GEO; GSM185873
DR   GEO; GSM997731
DR   GEO; GSM997732
DR   GEO; GSM997733
DR   GEO; GSM997734
DR   GEO; GSM997739
DR   GEO; GSM997740
DR   GEO; GSM997741
DR   GEO; GSM997742
DR   GEO; GSM997747
DR   GEO; GSM997748
DR   GEO; GSM997749
DR   GEO; GSM997750
DR   GEO; GSM1039261
DR   GEO; GSM1039262
DR   GEO; GSM1039263
DR   PubChem_Cell_line; CVCL_3871
DR   TOKU-E; 4035
DR   TOKU-E; 4044
DR   Wikidata; Q54813506
RX   PubMed=1497905;
RX   PubMed=9308922;
RX   PubMed=11431363;
RX   PubMed=16354588;
RX   PubMed=24705471;
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 24 hours (PubMed=1497905).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=1497905; DOI=10.1165/ajrcmb/7.2.161;
RA   Yang P.-C., Luh K.-T., Wu R., Wu C.-W.;
RT   "Characterization of the mucin differentiation in human lung
RT   adenocarcinoma cell lines.";
RL   Am. J. Respir. Cell Mol. Biol. 7:161-171(1992).
//
RX   PubMed=9308922; DOI=10.1165/ajrcmb.17.3.2837;
RA   Chu Y.-W., Yang P.-C., Yang S.-C., Shyu Y.-C., Hendrix M.J.C., Wu R.,
RA   Wu C.-W.;
RT   "Selection of invasive and metastatic subpopulations from a human lung
RT   adenocarcinoma cell line.";
RL   Am. J. Respir. Cell Mol. Biol. 17:353-360(1997).
//
RX   PubMed=11431363;
RA   Chen J.J.W., Peck K., Hong T.-M., Yang S.-C., Sher Y.-P., Shih J.-Y.,
RA   Wu R., Cheng J.-L., Roffler S.R., Wu C.-W., Yang P.-C.;
RT   "Global analysis of gene expression in invasion by a lung cancer
RT   model.";
RL   Cancer Res. 61:5223-5230(2001).
//
RX   PubMed=16354588; DOI=10.1593/neo.05640;
RA   Shieh Y.-S., Lai C.-Y., Kao Y.-R., Shiah S.-G., Chu Y.-W., Lee H.-S.,
RA   Wu C.-W.;
RT   "Expression of axl in lung adenocarcinoma and correlation with tumor
RT   progression.";
RL   Neoplasia 7:1058-1064(2005).
//
RX   PubMed=24705471; DOI=10.1371/journal.pone.0094065;
RA   Sher Y.-P., Wang L.-J., Chuang L.-L., Tsai M.-H., Kuo T.-T.,
RA   Huang C.-C., Chuang E.Y., Lai L.-C.;
RT   "ADAM9 up-regulates N-cadherin via miR-218 suppression in lung
RT   adenocarcinoma cells.";
RL   PLoS ONE 9:E94065-E94065(2014).
//
RX   PubMed=25060522; DOI=10.1158/0008-5472.CAN-13-2995;
RA   Lin C.-Y., Chen H.-J., Huang C.-C., Lai L.-C., Lu T.-P., Tseng G.-C.,
RA   Kuo T.-T., Kuok Q.-Y., Hsu J.L., Sung S.-Y., Hung M.-C., Sher Y.-P.;
RT   "ADAM9 promotes lung cancer metastases to brain by a plasminogen
RT   activator-based pathway.";
RL   Cancer Res. 74:5229-5243(2014).
//